Volume 41, Issue 5, Pages (November 2004)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
m-TOR inhibitors: What role in liver transplantation?
m-TOR inhibitors: What role in liver transplantation?
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
The use of technetium tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection  Patrick W. Vriens, MDa, Francis G. Blankenberg,
Immigration and viral hepatitis
A Role for TNF Receptor Type II in Leukocyte Infiltration into the Lung during Experimental Idiopathic Pneumonia Syndrome  Gerhard C. Hildebrandt, Krystyna.
The evidence supports a viral aetiology for primary biliary cirrhosis
Allogeneic hematopoietic cell transplant in HCV-infected patients
Living donor liver transplantation: is the hype over?
Adenoviral-mediated expression of antisense RNA to basic fibroblast growth factor reduces tangential stress in arterialized vein grafts  Abigail K. Hanna,
Volume 41, Issue 5, Pages (November 2004)
The place of downstaging for hepatocellular carcinoma
G.-I. Im, H.-J. Kim  Osteoarthritis and Cartilage 
Marina Berenguer, Detlef Schuppan  Journal of Hepatology 
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Hepatitis C core protein – The “core” of immune deception?
Volume 42, Issue 4, Pages (April 2005)
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Burcin Ekser, Eric Lagasse  Journal of Hepatology 
Volume 44, Issue 5, Pages (May 2006)
Transgene Expression in the Brain Stem Effected by Intramuscular Injection of Polyethylenimine/DNA Complexes  Shu Wang, Nan Ma, Shujun J. Gao, Hanry Yu,
Aloysious D. Aravinthan, Graeme J.M. Alexander  Journal of Hepatology 
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Gene therapy for lung cancer: Enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer 
Volume 43, Issue 4, Pages (October 2005)
JNK mediates hepatic ischemia reperfusion injury
EASL Clinical Practice Guidelines: Wilson’s disease
De novo autoimmune hepatitis after liver transplantation
Age and liver transplantation
Volume 6, Issue 2, Pages (August 2002)
Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host.
EASL Clinical Practice Guidelines on hepatitis E virus infection
Volume 41, Issue 6, Pages (December 2004)
Fen Huang, Chenchen Yang, Xinying Zhou, Wenhai Yu, Qiuwei Pan 
Liver stem cells—prospects for clinical use
Volume 56, Issue 6, Pages (June 2012)
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
Diagnostic value of quantitative PCR for adenovirus detection in stool samples as compared with antigen detection and cell culture in haematopoietic stem.
Volume 124, Issue 1, Pages (January 2003)
Induction of Angiopoietin-2 gene expression by COX-2: A novel role for COX-2 inhibitors during hepatocarcinogenesis  Shinji Tanaka, Jack R. Wands, Shigeki.
Volume 63, Issue 1, Pages (July 2015)
Volume 15, Issue 4, Pages (April 2007)
Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection  Isabelle Chemin,
The use of hemospray in portal hypertensive bleeding; a case series
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines 
m-TOR inhibitors: What role in liver transplantation?
Volume 61, Issue 2, Pages (August 2014)
HCV animal models and liver disease
Liver transplantation in children
Persistent Transgene Expression and Normal Differentiation of Immortalized Human Keratinocytes In Vivo  Gerald G. Krueger, Cynthia M. Jorgensen, Andrew.
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
The origin of biliary strictures after liver transplantation: Is it the amount of epithelial injury or insufficient regeneration that counts?  Negin Karimian,
Niya Aleksieva, Stuart J. Forbes  Journal of Hepatology 
Volume 64, Issue 3, Pages (March 2016)
Volume 11, Issue 2, Pages (February 2005)
Presentation transcript:

Volume 41, Issue 5, Pages 714-720 (November 2004) Patterns of transgene expression and viral clearance from the transplanted liver following ex vivo adenovirus-mediated gene transfer  Gideon Zamir, Andrew E. Gelman, Kim M. Olthoff, Fotini Debonera, Xavier Aldeguer, Abraham Shaked  Journal of Hepatology  Volume 41, Issue 5, Pages 714-720 (November 2004) DOI: 10.1016/j.jhep.2004.07.008 Copyright © 2004 European Association for the Study of the Liver Terms and Conditions

Fig. 1 (I) The effect of immunosuppression on the level and persistence of transgene (lacZ) expression in the transplanted liver following ex vivo infection of the liver graft with AdlacZ. (A) Syngeneic OLT (Lewis donor to Lewis recipient). Recipients received no immunosuppression, Cyclosporine A, or transplanted with grafts co-infected with AdCTLA-4Ig. (B) Allogeneic OLT (ACI donor to Lewis recipient) or ACI to nude (athymic) recipients. The level of expression was determined by counting the number of hepatocytes showing positive X-gal staining. (II) Disappearance of β-gal expression from the transplanted liver following AdlacZ ex vivo infection. X-gal staining of representative liver sections at different times after allogeneic liver transplantation (ACI to Lewis). Liver grafts were infected ex vivo with AdlacZ and AdCTLA-4Ig. Despite efficient control of the alloimmune response by local expression of CTLA-4Ig, lacZ expression ceases by day 30 after transplantation. Journal of Hepatology 2004 41, 714-720DOI: (10.1016/j.jhep.2004.07.008) Copyright © 2004 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Clearance of adenovirus DNA from the transplanted liver. Agarose gel analysis of different AdlacZ DNA sequences after PCR amplification. Whole liver DNA was analyzed at different times after syngeneic liver transplantation under no immunosuppression, Cyclosporine treatment or AdCTLA-4Ig co-infection. Smaller DNA fragments (E4 0.6kb>1kb lacZ>3kb lacZ) persist longer in the liver with no apparent prolongation by immunosuppression. Journal of Hepatology 2004 41, 714-720DOI: (10.1016/j.jhep.2004.07.008) Copyright © 2004 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Post transplantation liver damage and hepatocyte turnover. (A) BrdU immunohistochemistry. Hepatocyte DNA replication is demonstrated by BrdU immunohistochemistry in normal liver and 10 days after ex vivo gene transfer and transplantation. Brown stained nuclei represent BrdU-positive hepatocytes. In the allogeneic or syngeneic setting, there is only mild hepatocyte turnover (≈10% of hepatocytes) after adenovirus infection and transplantation. (B) AST levels following transplantation of syngeneic or allogeneic liver grafts. In rats receiving unmanipulated syngeneic grafts, there is a mild transient elevation in AST most probably due to ischemia-reperfusion injury. Adenovirus-mediated gene transfer per se does not result in additional liver injury. In allogeneic transplantation there is massive liver damage in untreated recipients which is mostly abrogated by local expression of CTLA-4Ig. Journal of Hepatology 2004 41, 714-720DOI: (10.1016/j.jhep.2004.07.008) Copyright © 2004 European Association for the Study of the Liver Terms and Conditions